Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Plos Computational Biology|April 2, 2026
Identifying the optimal rapid antigen test for screening and determining the end of isolation: A modeling studyYong Dam Jeong, William S Hart, Masahiro Ishikane, et al.
Plos Computational Biology|March 11, 2024
Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markersKosaku Kitagawa, Kwang Su Kim, Masashi Iwamoto, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation for analyzing extracellular viral markersKosaku Kitagawa, Kwang Su Kim, Masashi Iwamoto, et al.
Plos Pathogens|March 27, 2023
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivirShiho Torii, Kwang Su Kim, Jun Koseki, et al.
Journal of Medical Virology|February 2, 2026
Comparing Cross-Sectional and Longitudinal Study Designs for Accurate Viral Dynamics Estimation: Insights From the NBA Cohort DataJihyeon Kim, Hyeongki Park, Hoong Kai Chua, et al.
Cell Reports Methods|April 27, 2022
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents <i>in vitro</i>Kouki Matsuda, Saiful Islam, Toru Takada, et al.
Plos Medicine|July 6, 2021
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling studyShoya Iwanami, Keisuke Ejima, Kwang Su Kim, et al.
Antiviral Research|July 7, 2022
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa, et al.
Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.
The Journal of Infectious Diseases|March 9, 2023
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as TreatmentsDaisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.
Pageof 6